This article is more than 5 years old. Information may no longer be current.

VIDEO: Future potential for cross-linking

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK – Now that Avedro’s corneal cross-linking system is FDA-approved, the procedure provides potential for expanded uses, said Scott Hauswirth, OD, who presented a lecture on the topic here at Vision Expo East.

Much work is being done in the area of cross-linking as an anti-infective agent in infectious keratitis, he said. In addition, combination therapies are being considered with topography-guided PRK, conductive keratoplasty and Intacs (SightLife Surgical).